Topics and Expertise: COVID-19

QBI continues research efforts to stave off future surges of COVID-19

Wed Jun 30, 2021
Cell surrounded by viral particles
NIAID/NIH

A cell (blue) heavily infected with SARS-CoV-2 virus particles (green), isolated from a patient sample.

Research into SARS-CoV-2 variants and potential therapies pushes forward

Employees urged to submit COVID-19 vaccination records

Mon May 10, 2021
If you did not receive your vaccination at UCSF, you can submit your documentation via the Occupational Health Portal website.

A reliable test for COVID-19 immunity

Wed Apr 28, 2021
Viral particles and cells
NIAID/NIH

SARS-CoV-2 particles (magenta) emerging from the surface of cells cultured in the lab.

The Wells Lab developed an efficient test for SARS-CoV-2 antibodies

Update from the Dean: Recovery and resilience after a pandemic year

Thu Mar 11, 2021
Guglielmo
Elisabeth Fall

B. Joseph Guglielmo, PharmD

All the latest on COVID-19 vaccinations, a careful return to in-person education, science, and more.

New fund supports faculty members struggling with pandemic-related career disruptions

Mon Mar 1, 2021
Man throwing child into the air
Susan Merrell
The Faculty Resource Fund is offering two levels of awards to support faculty members affected by COVID-19 pandemic. The deadline to apply is March 9.

Cancer drug stops SARS-CoV-2 in the lab

Thu Feb 11, 2021
sea squirt.
PharmaMar

Aplidin is extracted from Aplidium albicans, a sea squirt found off the coast of Spain.

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

How we know it’s safe to get the vaccine

Thu Dec 17, 2020
A man wearing a mask measures vaccine in a syringe.
Susan Merrell

Preparing the Pfizer vaccine for injection.

UCSF experts address the safety of the new COVID-19 vaccines

Update from the Dean: Community during challenging times

Thu Nov 19, 2020
Guglielmo receives flu shot
Levi Gadye

Dean B. Joseph Guglielmo, PharmD, received his annual flu shot from Joe Li, Class of 2021.

The School continues its vital work in research, education, and patient care.

Jamming the gears of a deadly virus

Fri Nov 13, 2020
Spike protein
NIH

A 3D printed model of a SARS-CoV-2 viral particle (blue) dotted with the spike protein (red) that enables the virus to infect human cells. The spike protein is the target of research efforts to prevent and treat COVID-19.

Team efforts at the School and beyond produce two potential treatments for COVID-19.

QBI probes three lethal coronaviruses to find possible drug targets

Fri Oct 23, 2020
Blue dots show MERS-CoV particles on the surface of a cell
National Institute of Allergy and Infectious Diseases (NIAID)

Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles under an electron microscopic.

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

Pages